A PHASE 2, OPEN-LABEL, SINGLE-ARM, PROSPECTIVE, MULTICENTER STUDY OF NAB-SIROLIMUS PLUS LETROZOLE IN ADVANCED OR RECURRENT ENDOMETRIOID ENDOMETRIAL CANCER

被引:0
|
作者
Dockery, Lauren [1 ]
Musa, Fernanda [2 ]
Mathews, Cara [3 ]
Spirtos, Nick [4 ]
Slomovitz, Brian [5 ,6 ]
Priebe, Anna [7 ]
Green, Angela [8 ]
Puechl, Allison [9 ]
Birrer, Michael [10 ]
Herzog, Thomas [11 ]
Ding, Li [12 ]
Schmid, Anita [12 ]
Navarro, Willis [12 ]
Moore, Kathleen [13 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA
[2] Swedish Canc Inst, Seattle, WA USA
[3] Women & Infants Hosp Rhode Isl, Providence, RI USA
[4] Womens Canc Ctr Nevada, Las Vegas, NV USA
[5] Florida Int Univ, Mt Sinai Med Ctr, Dept Gynecol Oncol, Miami Beach, FL USA
[6] Florida Int Univ, Dept Obstet & Gynecol, Miami Beach, FL USA
[7] Texas Oncol, Ft Worth, TX USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Atrium Hlth, Charlotte, NC USA
[10] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR USA
[11] Univ Cincinnati, Canc Ctr, Cincinnati, OH USA
[12] Aadi Biosci, Pacific Palisades, CA USA
[13] Oklahoma Univ Hlth, Stephenson Canc Ctr, Oklahoma City, OK USA
关键词
D O I
10.1136/ijgc-2024-IGCS.606
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TP004/#156
引用
收藏
页码:A348 / A348
页数:1
相关论文
共 50 条
  • [41] A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancer
    Feng, J.
    Shen, B.
    Xu, J.
    Wang, Q.
    Ling, G.
    Mao, Y.
    Cai, M.
    Yang, Y.
    Mei, J.
    Han, Z.
    Wu, Y.
    Shi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S913 - S913
  • [42] A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia
    Hamauchi, Satoshi
    Furuse, Junji
    Takano, Toshimi
    Munemoto, Yoshinori
    Furuya, Ken
    Baba, Hideo
    Takeuchi, Manabu
    Choda, Yasuhiro
    Higashiguchi, Takashi
    Naito, Tateaki
    Muro, Kei
    Takayama, Koichi
    Oyama, Shusuke
    Takiguchi, Toru
    Komura, Naoyuki
    Tamura, Kazuo
    CANCER, 2019, 125 (23) : 4294 - 4302
  • [43] Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: A single-arm, open-label, phase 2 trial
    Wei, Zhigong
    Zhu, Yuchun
    Cai, Lei
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] A prospective, single-arm, open-label, phase II clinical trial on efficacy and safety of cadonilimab plus anlotinib for recurrent, metastatic or persistent cervical cancer
    Yang, Chunxu
    Sun, Shaoxing
    Xiang, Qingming
    Chen, Min
    Mei, Zijie
    Wu, Qiuji
    Qiu, Hui
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S290 - S290
  • [45] Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
    Deng, Li-Juan
    Zhou, Ke-Shu
    Liu, Li-Hong
    Zhang, Ming-Zhi
    Li, Zhi-Ming
    Ji, Chun-Yan
    Xu, Wei
    Liu, Ting
    Xu, Bing
    Wang, Xin
    Gao, Su-Jun
    Zhang, Hui-Lai
    Hu, Yu
    Li, Yan
    Cheng, Ying
    Yang, Hai-Yan
    Cao, Jun-Ning
    Zhu, Zun-Min
    Hu, Jian-Da
    Zhang, Wei
    Jing, Hong-Mei
    Ding, Kai-Yang
    Zhang, Xiang-Yang
    Zhao, Ren -Bin
    Zhang, Bin
    Tian, Ya -Min
    Song, Yong-Ping
    Song, Yu-Qin
    Zhu, Jun
    BLOOD ADVANCES, 2023, 7 (16) : 4349 - 4357
  • [46] Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Chau, Quincy
    Ramchandren, Radhakrishnan
    BLOOD, 2012, 120 (21)
  • [47] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Tsuyoshi Matsumura
    Hiroya Hashimoto
    Masahiro Sekimizu
    Akiko M. Saito
    Yasufumi Motoyoshi
    Akinori Nakamura
    Satoshi Kuru
    Takayasu Fukudome
    Kazuhiko Segawa
    Toshiaki Takahashi
    Takuhisa Tamura
    Tetsuo Komori
    Chigusa Watanabe
    Masanori Asakura
    Koichi Kimura
    Yuko Iwata
    Orphanet Journal of Rare Diseases, 17
  • [48] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Matsumura, Tsuyoshi
    Hashimoto, Hiroya
    Sekimizu, Masahiro
    Saito, Akiko M.
    Motoyoshi, Yasufumi
    Nakamura, Akinori
    Kuru, Satoshi
    Fukudome, Takayasu
    Segawa, Kazuhiko
    Takahashi, Toshiaki
    Tamura, Takuhisa
    Komori, Tetsuo
    Watanabe, Chigusa
    Asakura, Masanori
    Kimura, Koichi
    Iwata, Yuko
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [49] A single-arm, open-label, multicenter study of tranilast for advanced heart failure in patients with muscular dystrophy
    Matsumura, T.
    Hashimoto, H.
    Sekimizu, M.
    Saito, A.
    Asakura, M.
    Kimura, K.
    Iwata, Y.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S103 - S103
  • [50] Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study
    You, Liangshun
    Liu, Yi
    Mai, Wenyuan
    Xie, Wanzhuo
    Zhou, De
    Mao, Liping
    Chen, Lili
    Zhou, Xinping
    Ma, Liya
    Zheng, Xiaolong
    Wei, Juying
    Lou, Yinjun
    Ye, Xingnong
    Tong, Hongyan
    Jin, Jie
    Meng, Haitao
    EUROPEAN JOURNAL OF CANCER, 2024, 202